Nanalysis Scientific Corp. Announces Grant of Stock Options

Rhea-AI Summary

Nanalysis Scientific Corp. (OTCQX:NSCIF) announced the granting of 620,000 stock options to directors and officers at an exercise price of $1.32 per share, valid for five years. The options will vest in three stages: one-third after 12, 24, and 36 months. This strategic move aims to incentivize leadership and align their interests with shareholders.

Positive

• Granting of 620,000 stock options may incentivize management and align interests with shareholders.
• Exercise price set at $1.32 per share could reflect confidence in the company's future performance.

Negative

• None.

CALGARY, AB, March 3, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted a total of 620,000 stock options to its directors and officers pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.32 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month and 36 month anniversary date of grant.  

About Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-scientific-corp-announces-grant-of-stock-options-301495004.html

SOURCE Nanalysis Scientific Corp.

FAQ

What stock options were announced by Nanalysis Scientific Corp. on March 3, 2022?

Nanalysis announced the granting of 620,000 stock options to directors and officers at an exercise price of $1.32 per share.

How long are the stock options valid for Nanalysis Scientific Corp.?

The stock options are valid for five years from the date of issuance.

When will the stock options vest for Nanalysis Scientific Corp. directors and officers?

The options will vest in three stages: one-third after 12 months, another third after 24 months, and the final third after 36 months.

What is the ticker symbol for Nanalysis Scientific Corp. on OTCQX?

The ticker symbol for Nanalysis on the OTCQX is NSCIF.